Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
1 other identifier
observational
200
1 country
1
Brief Summary
This study aims to evaluate the neurobiological basis of traumatic dissociation in a cross-diagnostic sample of women who have histories of childhood abuse and neglect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 17, 2016
CompletedFirst Posted
Study publicly available on registry
May 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
October 27, 2025
October 1, 2025
11 years
March 17, 2016
October 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline correlates of traumatic dissociation in Functional Magnetic Resonance Imaging at 36 to 56 weeks
Study participation will involve a baseline 60 minute cognitive assessment and a 60 minute Magnetic Resonance Imaging (MRI) at the 3 Tesla magnet in the McLean Hospital Imaging Center focusing on attention, emotion regulation, and symptoms of depersonalization. The first time point is baseline.The second time point will be 36-56 weeks after the baseline 60 minute Magnetic Resonance Imaging (MRI) scan at the 3 Tesla magnet in the McLean Hospital Imaging Center.
Baseline and 36 to 56 weeks after baseline
Study Arms (2)
Women with History of Childhood Abuse
The study will enroll up to 140 female patients with either DID or PTSD ages 18-89
Healthy Control Group
We will recruit up to 60 control subjects matched for demographics (age, race, gender).
Eligibility Criteria
The study will enroll up to 90 female patients with either DID or PTSD ages 18-89. We will also recruit up to 60 control subjects matched for demographics (age, race, gender).
You may qualify if:
- Female
- Clinical diagnosis of PTSD or DID and history of childhood abuse, or healthy controls
- Age between 18 and 89
- Legal and mental competency of the patient
You may not qualify if:
- Male
- Under 18 or over 89
- Legal or mental incompetence
- Delirium secondary to medical illness
- PTSD or DID due to general medical or neurological illness
- History of neurological conditions that may cause significant psychiatric symptomatology (e.g., dementia)
- Any contraindication to MR scans, including claustrophobia, pregnancy, metal implants, etc.
- Current alcohol or substance dependence or abuse (within the last month)
- A history of schizophrenia or other psychotic disorder
- History of head injury or loss of consciousness for longer than 5 min (including concussion)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mclean Hospitallead
Study Sites (1)
McLean Hospital
Belmont, Massachusetts, 02478, United States
Biospecimen
Study participants will provide a 2mm saliva sample.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milissa L Kaufman, M.D./Ph.D
Mclean Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of The Dissociative Disorders and Trauma Research Program
Study Record Dates
First Submitted
March 17, 2016
First Posted
May 2, 2016
Study Start
June 1, 2015
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
October 27, 2025
Record last verified: 2025-10